Back to search

University of Thessaly (UTH)

Investigation of 2-deoxyglucose (2DG) as a modulator of mesothelial and endothelial cell membrane function in peritoneal dialysis

Abstract

dc:description

The Peritoneal Dialysis modality with the prolonged exposure to Peritoneal Dialysis Fluids (PDF) induce hyper-vascularization as well as peritoneal membrane thickening and fibrosis, ultimately leading to ultrafiltration failure. Therefore, there is intense scientific interest regarding the development of strategies that would delay the deterioration of the peritoneal membrane at a morphological and functional level. Recent evidence reported that mesothelial cells exposed to PDF with a high content in glucose degradation products (GDP) undergo metabolic reprogramming towards a more glycolytic phenotype associated with mesothelial-to-mesenchymal transition (MMT). However, addition of 2-deoxyglucose (2DG) inhibited the above process of MMT. In the present study, we investigated whether the 2DG effect is valid in mesothelial cells treated with low GDP PDF, and whether the same stands for endothelial cells as well. Furthermore, the effect of 2DG PDF supplementation was tested with regards to the mesothelial and endothelial barrier function. The antifibrotic effect of 2DG administration was confirmed through the collagen gel contraction assay with embedded mesothelial (MeT-5A) and endothelial (EA.hy926) cells cultured in Dianeal® 2.5% glucose (CPDF), BicaVera® 2.3% glucose (BPDF) and Balance® 2.3% glucose (LPDF) with or without the addition of 0.2 mM 2DG. Similar findings were obtained by performing qPCR for the αSMA and CDH2 genes. More specifically, the contractility of both MeT-5A and EA926 cells incubated with CPDF/2DG solution was reduced, accompanied by fold changes in αSMA and CDH2 gene expression. In the case of EA.hy926 cells, αSMA gene expression was also reduced under LPDF/2DG incubation. Regarding the effect of 2DG on permeability characteristics of the mesothelial and/or endothelial cell monolayers, it was assessed by monitoring the transmembrane resistance (RTM), FITC-labelled dextran (10, 70kDa) diffusion as well as gene expression levels of CLDN1, CLDN2, CLDN-3, CLDN4, CLDN5, ZO1, SGLT1 and SGLT2. Overall, the addition of 2DG attenuated the PDF-induced perturbations in mesothelial and/or endothelial barrier function, as shown by RTM values, dextran transport rate, and gene expression levels of CLDN-1 to -5, ZO1, and SGLT2, while its effect was more evident in MeT-5A cell monolayers. Therefore, supplementation of all types of PDF with 2DG not only mitigates MMT but also improves the functional permeability characteristics of the mesothelial and endothelial barrier of peritoneal membrane.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Pitaraki, Eleanna
  • Πιταράκη, Ελεάννα

Subjects

dc:subject × 22

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/55953

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Pitaraki, Eleanna; Πιταράκη, Ελεάννα. Investigation of 2-deoxyglucose (2DG) as a modulator of mesothelial and endothelial cell membrane function in peritoneal dialysis. University of Thessaly (UTH), 2024. http://hdl.handle.net/10442/hedi/55953